Prosecution Insights
Last updated: August 18, 2026

Examiner: PIPIC, ALMA

Tech Center 1700 • Art Units: 1617 1645 1767

This examiner grants 54% of resolved cases

Performance Statistics

54.3%
Allow Rate
-10.7% vs TC avg
766
Total Applications
+55.2%
Interview Lift
1142
Avg Prosecution Days
Based on 716 resolved cases, 2023–2026

Rejection Statute Breakdown

0.8%
§101 Eligibility
7.7%
§102 Novelty
44.0%
§103 Obviousness
31.5%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18491871 MODIFIED RELEASE FORMULATIONS OF PRIDOPIDINE Final Rejection Prilenia Neurotherapeutics Ltd.
18141138 NANOFIBROUS TISSUE ENGINEERING MATRICES WITH IMPROVED CLINICAL HANDLING PROPERTIES FOR PERIODONTAL AND CRANIOFACIAL REGENERATION AND METHODS OF MAKING THE SAME Non-Final OA REGENTS OF THE UNIVERSITY OF MICHIGAN
17923448 EMULSIFIER AND EMULSION COMPOSITION CONTAINING SAME Non-Final OA SHIN-ETSU CHEMICAL CO., LTD.
18412205 REVERSE THERMAL GELS AND THEIR USE AS VASCULAR EMBOLIC REPAIR AGENTS Non-Final OA The Regents Of The University Of Colorado, A Body Corporate
17626469 MULTI-AGENT OCULAR FORMULATIONS AND TREATMENT METHODS Final Rejection University of Utah Research Foundation
18306872 NON-LINEAR MULTIBLOCK COPOLYMER-DRUG CONJUGATES FOR THE DELIVERY OF ACTIVE AGENTS Final Rejection The Johns Hopkins University
17962515 PROCESS FOR ALTERING THE COLOR OF KERATIN FIBERS Non-Final OA L'Oreal
17625962 Herbicidal Mixtures Containing Amine Salts of Acidic Herbicides Non-Final OA MONSANTO TECHNOLOGY LLC
18902135 POLYMER NANOPARTICLE COMPOSITIONS FOR NON-VIRAL GENE DELIVERY TO THE CENTRAL NERVOUS SYSTEM Non-Final OA BATTELLE MEMORIAL INSTITUTE
18729020 LIPIDIC COMPOUNDS, AND USES THEREOF Non-Final OA SANOFI
17753795 STICKER FORMULATION CONTAINING A SULFOPOLYMER Non-Final OA Eastman Chemical Company
17949484 CURABLE COMPOUNDS AND FORMULATIONS FOR BIOMEDICAL APPLICATIONS Final Rejection 3D SYSTEMS, INC.
18833322 RADIOSENSITIZING COMPOSITIONS AND METHODS OF USE THEREOF Non-Final OA University of Georgia Research Foundation, Inc.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month